Introduction 7.622384
: 2.5079741
Ċ 1.0427654
In 9.83602
Ġthe 1.677565
Ġrelentless 11.024809
Ġfight 4.6747847
Ġagainst 0.8272179
Ġcancer 4.0869265
, 0.45043308
ĠBritish 9.468654
ĠBi 7.599283
otech 1.9698845
ĠPl 7.863351
c 0.021791037
's 3.7492049
Ġexperimental 8.883101
Ġdrug 1.8622409
, 1.9182291
ĠMar 7.5324078
im 5.0181866
ast 5.9556694
at 0.19756313
, 0.44722164
Ġhas 0.8556935
Ġemerged 3.1871176
Ġas 0.32810166
Ġa 0.95278627
Ġpromising 2.4702346
Ġcandidate 2.2268581
Ġfor 1.2300158
Ġpotentially 5.9768014
Ġrevolution 5.703216
izing 0.53726447
Ġcancer 1.6433722
Ġtreatment 0.5520884
. 0.24676006
ĠEarly 6.8265347
Ġresults 1.7046016
Ġand 6.5006576
Ġencouraging 5.2770715
Ġdata 3.1509218
Ġhave 2.386279
Ġraised 3.9397204
Ġhopes 0.36156893
Ġfor 1.5005194
Ġan 2.980353
Ġeffective 2.4722724
Ġtherapy 3.6481473
, 2.2460384
Ġbut 1.0275315
Ġthe 1.6934353
Ġdrug 2.9504902
Ġstill 3.526669
Ġfaces 2.1836185
Ġsignificant 3.1101372
Ġobstacles 2.9477556
Ġbefore 4.4184246
Ġit 0.6096646
Ġcan 0.62302816
Ġachieve 4.1024065
Ġblockbuster 5.6205726
Ġstatus 0.18198195
. 0.16069388
ĠAs 4.058516
Ġthe 1.93124
Ġbiotech 5.429162
Ġindustry 1.3748481
Ġeagerly 6.972796
Ġawaits 0.50875235
Ġfurther 3.8462713
Ġadvancements 6.5466638
, 0.8942972
Ġthe 2.1026404
Ġroad 8.134962
Ġahead 0.27717793
Ġfor 1.461087
ĠMar 0.80680937
im 0.00096947496
ast 0.0011468077
at 0.001281261
Ġremains 3.0208788
Ġuncertain 1.7224967
Ġdue 5.470323
Ġto 0.032507394
Ġregulatory 3.2814157
Ġchallenges 2.8260202
, 1.272322
Ġintense 6.005242
Ġcompetition 0.6592728
, 0.76851183
Ġand 0.2527444
Ġpotential 4.708151
Ġfinancial 4.001313
Ġhurdles 4.583407
. 0.16451886
Ċ 1.2125866
Reg 7.83231
ulatory 0.08207913
ĠChallenges 1.5758259
: 0.36732453
Ċ 1.990979
Despite 2.4616773
Ġdemonstrating 8.141145
Ġpromise 2.7019124
, 1.2691032
ĠMar 0.75397605
im 0.00031203084
ast 0.00095318665
at 0.0002322596
Ġmust 5.562653
Ġnavigate 3.8130305
Ġa 1.6066711
Ġcomplex 1.4078964
Ġand 2.7702382
Ġrigorous 6.1888156
Ġregulatory 0.38773927
Ġprocess 2.0604289
Ġbefore 1.190338
Ġreaching 4.8269053
Ġthe 1.238921
Ġmarket 0.85676533
. 0.19743794
ĠThe 1.7050089
Ġdrug 2.3631568
's 1.5195581
Ġefficacy 4.8233166
Ġand 1.0234593
Ġsafety 0.0909048
Ġprofile 2.8800654
Ġwill 3.7839572
Ġbe 0.83237743
Ġcritically 4.491804
Ġreviewed 3.5431592
Ġby 0.704773
Ġregulatory 2.4964983
Ġauthorities 1.4416695
Ġsuch 4.676248
Ġas 0.0047964035
Ġthe 0.10486579
ĠU 2.1456072
. 0.0005385048
S 0.04044082
. 0.07878538
ĠFood 0.024546394
Ġand 0.028824735
ĠDrug 0.0013175473
ĠAdministration 0.00707703
Ġ( 0.32969773
F 0.024000688
DA 0.0008165726
) 0.5792605
Ġand 0.22232942
Ġthe 0.40109175
ĠEuropean 0.37660915
ĠMedic 0.103994384
ines 0.001310743
ĠAgency 0.0037414893
Ġ( 0.08811597
EMA 0.01345258
). 0.62573093
ĠGiven 5.072171
Ġthe 0.4927861
Ġstringent 5.6445923
Ġrequirements 2.4419048
Ġand 2.4735515
Ġextensive 4.1355495
Ġtesting 2.2883353
Ġphases 5.839559
Ġinvolved 2.6931667
, 0.62264174
ĠBritish 7.781018
ĠBi 0.055218406
otech 0.004088974
ĠPl 0.43772653
c 0.00034726874
Ġmust 2.8769963
Ġaddress 5.542327
Ġany 5.6565323
Ġpotential 1.9951153
Ġconcerns 2.8708942
Ġor 2.8510547
Ġside 6.8955398
Ġeffects 0.2417309
Ġto 3.216716
Ġensure 0.7710915
ĠMar 3.5193899
im 0.00037636596
ast 0.0005443507
at 0.0002528855
's 0.8076974
Ġsuccessful 4.601887
Ġjourney 8.904261
Ġthrough 3.282059
Ġregulatory 3.0603259
Ġapproval 1.7811002
. 0.58128357
Ċ 0.5484524
Int 7.502102
ense 1.6237351
ĠCompetition 1.1085626
Ġand 4.471705
ĠMarket 5.3622136
ĠLand 7.6675115
scape 0.12998734
: 0.0829295
Ċ 0.0043152287
Mar 4.018887
im 0.0017916069
ast 0.00063870015
at 0.00015553238
Ġenters 6.927348
Ġa 1.8019103
Ġfiercely 3.2393982
Ġcompetitive 0.007692202
Ġmarket 1.2880471
, 1.9703418
Ġchallenging 7.260692
Ġestablished 2.8038237
Ġplayers 1.8589357
Ġwho 4.6596255
Ġhave 0.88489103
Ġalready 2.9220276
Ġmade 3.9671845
Ġsignificant 0.75039583
Ġstrides 2.1148474
Ġin 0.3289548
Ġcancer 2.9448228
Ġtreatment 0.9926322
. 0.4830639
ĠR 6.9576263
ival 0.30770996
Ġpharmaceutical 3.7909832
Ġcompanies 0.31435972
Ġhave 1.8089132
Ġinvested 3.4216173
Ġheavily 1.2596501
Ġin 0.25566465
Ġdeveloping 1.9707868
Ġcutting 6.468692
- 0.26454356
edge 0.00069685513
Ġtherapies 2.5229332
, 1.2295445
Ġsome 6.4214964
Ġof 0.3996301
Ġwhich 0.052672878
Ġhave 0.90751874
Ġgained 4.5863028
Ġregulatory 4.4294677
Ġapproval 0.1368866
Ġand 2.0053713
Ġachieved 4.750719
Ġimpressive 4.085566
Ġclinical 3.210267
Ġoutcomes 3.2201848
. 0.1960139
ĠBritish 2.8522618
ĠBi 0.024129514
otech 0.0017153558
ĠPl 0.04613662
c 0.00020215422
Ġmust 2.502536
Ġfind 4.8705745
Ġits 5.014682
Ġplace 3.2832398
Ġwithin 2.6398492
Ġthis 0.58364534
Ġcrowded 2.9501104
Ġlandscape 3.7225916
Ġby 3.2069924
Ġdemonstrating 3.97878
Ġa 2.3155262
Ġunique 4.358928
Ġvalue 4.7784224
Ġproposition 0.26641336
Ġand 1.355415
Ġdifferent 8.7265625
iating 0.091694504
ĠMar 3.4037948
im 0.00021777152
ast 0.00030344594
at 9.759038e-05
Ġfrom 0.44140694
Ġexisting 2.9844775
Ġtreatment 4.043797
Ġoptions 0.15850016
. 0.22763285
Ċ 0.93280435
Financial 8.623289
ĠCon 3.7789817
str 0.033475243
aints 0.015207992
Ġand 3.5140448
ĠMarket 3.981395
ĠAccess 5.0150375
: 0.21011868
Ċ 0.0015668162
Develop 5.658805
ing 0.14616288
Ġand 2.760842
Ġlaunching 3.838611
Ġa 0.36146414
Ġgroundbreaking 6.062705
Ġcancer 2.2469792
Ġdrug 0.8679923
Ġis 1.0978552
Ġan 2.6635256
Ġexpensive 1.591836
Ġendeavor 1.3535545
, 1.2238783
Ġrequiring 2.1110725
Ġsubstantial 2.4365735
Ġfinancial 2.8559701
Ġresources 0.57686734
. 1.0814649
ĠBritish 1.8656063
ĠBi 0.010449417
otech 0.0015918294
ĠPl 0.023186104
c 0.00017460952
Ġmay 4.7396975
Ġface 2.4542718
Ġhurdles 5.450997
Ġin 0.5160823
Ġsecuring 1.7542517
Ġthe 2.107861
Ġfunding 2.5739963
Ġnecessary 1.1688507
Ġfor 2.624004
Ġthe 1.9963782
Ġdrug 3.1464612
's 0.4847606
Ġclinical 3.3939788
Ġtrials 1.9079831
, 1.3855464
Ġmanufacturing 4.753947
, 1.2511374
Ġand 0.46164784
Ġmarketing 1.2630548
Ġactivities 4.4731236
. 0.15845364
ĠAdditionally 4.380649
, 0.0014698085
Ġquestions 8.747632
Ġregarding 2.347017
Ġreimbursement 4.936247
Ġand 1.2930183
Ġmarket 3.7413898
Ġaccess 0.17971164
Ġalso 5.489651
Ġpose 4.2417088
Ġchallenges 1.9861876
. 1.1300608
ĠDemon 10.199516
str 0.031196827
ating 0.068794064
Ġthe 2.0881424
Ġcost 5.483169
- 0.70146346
effect 0.110579
iveness 0.00042138743
Ġand 2.0269697
Ġreal 7.263497
- 0.39974973
world 0.07937519
Ġbenefits 3.205377
Ġof 0.050687812
ĠMar 1.0711379
im 0.00046789853
ast 0.00071940065
at 0.00012167429
Ġwill 1.8829325
Ġbe 1.2244085
Ġcritical 2.1162472
Ġto 0.5443093
Ġsecuring 3.1736152
Ġinsurance 7.9613853
Ġcoverage 1.2435833
Ġand 1.0534537
Ġa 4.147309
Ġfair 5.0492024
Ġpricing 4.108735
Ġstructure 1.4447411
, 2.9199033
Ġa 5.0543523
Ġfactor 5.225095
Ġthat 0.36312255
Ġcan 3.885437
Ġgreatly 3.9571419
Ġinfluence 1.2026753
Ġits 3.2567575
Ġblockbuster 9.575584
Ġpotential 0.73675406
. 0.03860653
Ċ 0.75481755
Cl 5.90331
inical 0.03115821
ĠTrials 1.0729864
Ġand 2.02399
ĠOptim 7.821881
izing 1.7931669
ĠE 5.3717084
ffic 0.013975943
acy 0.007955487
: 0.22091271
Ċ 0.00396593
While 3.9227111
ĠMar 2.0181358
im 0.000151361
ast 0.0004256799
at 6.194322e-05
Ġhas 1.966075
Ġshown 2.5411303
Ġpromise 0.8265063
Ġin 1.1618547
Ġpre 2.0403228
clinical 0.20252366
Ġand 1.3027238
Ġearly 3.2704535
Ġclinical 0.5924416
Ġtrials 0.79697925
, 0.03505807
Ġits 2.2790496
Ġtrue 3.663812
Ġeffectiveness 4.0873923
Ġremains 2.757234
Ġto 1.2242314
Ġbe 0.0028163677
Ġseen 0.33743355
. 0.15233366
ĠAdv 8.071397
ancing 1.5793493
Ġto 3.8245077
Ġlate 4.7618995
- 0.41993845
stage 0.10691648
Ġclinical 0.7661511
Ġtrials 0.21975428
Ġwill 1.2878314
Ġprovide 3.5160391
Ġcrucial 4.1297646
Ġinsights 2.3302295
Ġand 3.1245494
Ġa 4.145458
Ġclearer 2.5382898
Ġunderstanding 0.46811742
Ġof 0.028282631
Ġthe 0.8026904
Ġdrug 0.758615
's 0.0063913246
Ġoverall 5.094612
Ġefficacy 1.5941496
Ġand 1.3830423
Ġpotential 3.89288
Ġside 2.1228871
Ġeffects 0.19191809
. 0.102829315
ĠBritish 2.568445
ĠBi 0.009148072
otech 0.001873475
ĠPl 0.012426644
c 0.0009482962
Ġmust 0.5935368
Ġensure 1.9771729
Ġthese 6.1350465
Ġtrials 1.8559564
Ġare 0.6550585
Ġconducted 0.7542325
Ġmeticulously 9.271523
Ġto 1.7618573
Ġmaximize 2.058372
ĠMar 3.9066668
im 0.0005568742
ast 0.00021479129
at 0.00013359329
's 0.0071221106
Ġtherapeutic 2.6952903
Ġbenefits 3.243511
Ġand 0.9253973
Ġminimize 0.44099385
Ġany 2.3702912
Ġrisks 2.7290392
. 0.80793154
Ċ 0.89413404
Conclusion 5.3259144
: 0.028374793
Ċ 0.051494457
As 3.427805
ĠBritish 2.4004161
ĠBi 0.009818273
otech 0.0017411498
ĠPl 0.024848996
c 0.00012882493
's 2.953152
Ġcancer 6.462596
Ġdrug 0.4372118
ĠMar 1.9881856
im 2.880226e-05
ast 0.00038614578
at 0.00010355082
Ġprogresses 3.8417757
Ġin 4.002966
Ġits 1.6298089
Ġdevelopment 1.5445694
, 1.0432318
Ġthe 1.1353649
Ġpath 5.478734
Ġtowards 3.3403144
Ġblockbuster 3.2189732
Ġstatus 0.22422445
Ġfaces 7.233387
Ġsignificant 1.6086694
Ġhurdles 1.3801996
. 0.5280544
ĠNav 10.106139
igating 0.0027754847
Ġthe 1.4106888
Ġcomplex 1.9686817
Ġweb 9.484263
Ġof 0.009527045
Ġregulatory 0.3742086
Ġrequirements 2.3735032
, 0.77357286
Ġcompeting 3.4876935
Ġagainst 5.6760006
Ġestablished 1.3518995
Ġplayers 0.77816457
, 0.27472007
Ġsecuring 6.7824926
Ġadequate 6.4653354
Ġfunding 1.0236635
, 0.28160357
Ġand 0.16108999
Ġoptimizing 3.5748923
Ġclinical 3.2219992
Ġtrial 2.0415103
Ġoutcomes 2.3062525
Ġare 1.5550859
Ġjust 3.7637768
Ġsome 0.3471395
Ġof 0.020930462
Ġthe 0.0077483645
Ġchallenges 0.5378355
Ġto 4.7714005
Ġovercome 0.8265885
. 0.88214403
ĠNevertheless 5.4350276
, 0.002292834
Ġthe 1.5395569
Ġimmense 7.7994037
Ġpotential 1.1709012
Ġand 2.7860012
Ġearly 5.9071445
Ġpromise 0.6351187
Ġexhibited 6.9281487
Ġby 0.039283756
ĠMar 0.64851934
im 0.00019952882
ast 0.000534095
at 7.684431e-05
Ġoffer 4.69893
Ġhope 2.3231652
Ġto 2.4565384
Ġpatients 2.9815784
Ġand 0.99133736
Ġthe 1.8344308
Ġwider 3.6127322
Ġmedical 3.1501296
Ġcommunity 0.17990056
. 0.6991707
ĠThe 2.8376644
Ġbiotech 3.8768358
Ġindustry 0.27263412
Ġeagerly 6.15889
Ġawaits 0.033303548
Ġthe 1.259604
Ġnext 1.6994097
Ġsteps 2.7192595
, 3.4736383
Ġas 3.2084577
Ġsuccessful 6.0286317
Ġnavigation 10.59671
Ġthrough 2.050183
Ġthese 3.2608237
Ġhurdles 2.5898728
Ġcould 3.244941
Ġpotentially 3.787958
Ġmake 4.386482
ĠMar 0.5981329
im 0.00015160035
ast 0.0002775683
at 0.00010534082
Ġa 0.8557559
Ġgame 1.8647937
- 0.6194567
ch 0.46190825
anger 0.000306903
Ġin 0.5533344
Ġcancer 0.5949018
Ġtreatment 0.2939709
. 0.099896975
